Business

Cresco Labs CEO: Rescheduling Marks Historic Shift for Cannabis Industry

CHICAGO, December 18, 2025--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company"), today issued a statement on behalf of Cresco Labs CEO Charlie Bachtell following President Trump’s action to reschedule cannabis from a Schedule I to Schedule III substance under the Controlled Substances Act.

articleCresco Labs, Inc.December 18, 20253/company/cresco-labs-inc/news/cresco-labs-ceo-rescheduling-marks-192200814
Cresco Labs CEO: Rescheduling Marks Historic Shift for Cannabis Industry

About this update from Cresco Labs, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":421,"url":"https://media.zenfs.com/en/business-wire.com/cac93e45b22c2d14af7b18b1f0b1e7e1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/itXrJuTGSB2rVWa2bQPizA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTg0MjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/cac93e45b22c2d14af7b18b1f0b1e7e1","width":480,"height":421}},"lazy":false},{"type":"text","content":"CHICAGO, December 18, 2025--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company"), today issued a statement on behalf of Cresco Labs CEO Charlie Bachtell following President Trump’s action to reschedule cannabis from a Schedule I to Schedule III substance under the Controlled Substances Act.","length":361,"tagName":"p"},{"type":"text","content":""Today marks the most consequential moment in the history of U.S. cannabis. The decision to move cannabis from Schedule I to Schedule III will be a cultural turning point, acknowledging what millions of Americans already know: cannabis is medicine and deserves responsible, common-sense regulation.","length":303,"tagName":"p"},{"type":"text","content":"This action starts bridging the gap between federal law and the will of the American people, with nearly 90 percent of Americans supporting some form of cannabis legalization and 74 percent already living in states with legal cannabis. Rescheduling unlocks opportunities for comprehensive medical research. It validates the work of state leaders who pioneered thoughtful, highly regulated cannabis programs for their constituents. It sends a strong message to our criminal justice system to stop imprisoning people for a plant that’s been used as medicine for more than 5,000 years.","length":582,"tagName":"p"},{"type":"text","content":"For the estimated 450,000 people working in the regulated cannabis industry, rescheduling is the first domino to fall, paving the way for cannabis to be normalized, respected and finally treated like any other U.S. industry. It will remove cannabis companies’ unfair tax burden, allowing operators to reinvest in new infrastructure and job growth in the communities we serve. It also lays essential groundwork for progress on banking reform and acces...

More updates from Cresco Labs, Inc.

Cresco LabsThe CompanyForward-Looking StatementsCompany